Efficacy, safety, and immunogenicity of the Shigella sonnei 1790GAHB GMMA candidate vaccine: Results from a phase 2b randomized, placebo-controlled challenge study in adults.

Frenck RW Jr, Conti V, Ferruzzi P, Ndiaye AGW, Parker S, McNeal MM, Dickey M, Granada JP, Cilio GL, De Ryck I, Necchi F, Suvarnapunya AE, Rossi O, Acquaviva A, Chandrasekaran L, Clarkson KA, Auerbach J, Marchetti E, Kaminski RW, Micoli F, Rappuoli R, Saul A, Martin LB, Podda A

Open source

DOI: 10.1016/j.eclinm.2021.101076
Published: 2021 Sep
Container: EClinicalMedicine
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.eclinm.2021.101076,
  title = {Efficacy, safety, and immunogenicity of the Shigella sonnei 1790GAHB GMMA candidate vaccine: Results from a phase 2b randomized, placebo-controlled challenge study in adults.},
  author = {Frenck RW Jr and Conti V and Ferruzzi P and Ndiaye AGW and Parker S and McNeal MM and Dickey M and Granada JP and Cilio GL and De Ryck I and Necchi F and Suvarnapunya AE and Rossi O and Acquaviva A and Chandrasekaran L and Clarkson KA and Auerbach J and Marchetti E and Kaminski RW and Micoli F and Rappuoli R and Saul A and Martin LB and Podda A},
  year = {2021},
  journal = {EClinicalMedicine},
  doi = {10.1016/j.eclinm.2021.101076},
  url = {https://doi.org/10.1016/j.eclinm.2021.101076}
}

RIS

TY  - JOUR
TI  - Efficacy, safety, and immunogenicity of the Shigella sonnei 1790GAHB GMMA candidate vaccine: Results from a phase 2b randomized, placebo-controlled challenge study in adults.
AU  - Frenck RW Jr
AU  - Conti V
AU  - Ferruzzi P
AU  - Ndiaye AGW
AU  - Parker S
AU  - McNeal MM
AU  - Dickey M
AU  - Granada JP
AU  - Cilio GL
AU  - De Ryck I
AU  - Necchi F
AU  - Suvarnapunya AE
AU  - Rossi O
AU  - Acquaviva A
AU  - Chandrasekaran L
AU  - Clarkson KA
AU  - Auerbach J
AU  - Marchetti E
AU  - Kaminski RW
AU  - Micoli F
AU  - Rappuoli R
AU  - Saul A
AU  - Martin LB
AU  - Podda A
PY  - 2021
JO  - EClinicalMedicine
DO  - 10.1016/j.eclinm.2021.101076
UR  - https://doi.org/10.1016/j.eclinm.2021.101076
ER  -

APA

Jr, F. R., V, C., P, F., AGW, N., S, P., MM, M., M, D., JP, G., GL, C., I, D. R., F, N., AE, S., O, R., A, A., L, C., KA, C., J, A., E, M., RW, K., F, M., R, R., A, S., LB, M., & A, P. (2021). Efficacy, safety, and immunogenicity of the Shigella sonnei 1790GAHB GMMA candidate vaccine: Results from a phase 2b randomized, placebo-controlled challenge study in adults.. EClinicalMedicine. https://doi.org/10.1016/j.eclinm.2021.101076

Source records

pubmed · retrieved 2026-09-26T19:16:59.438Z